Portugal
Change language:
Gilead Sciences, Lda.
Atrium Saldanha
Praça Duque de Saldanha, nº1 - 8ºA e B
1050-094 Lisboa
Portugal
Phone: +351 21 792 8790 +351 21 792 8790
Fax: +351 21 792 8799
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Gilead in Portugal has been in operation since February 1996. When the company first began operating, it was called Nexstar Farmacêutica Lda., and then in 2001 officially became Gilead Sciences Lda. Gilead’s office in Lisbon provides sales, marketing, medical and regulatory support for Gilead’s products throughout Portugal.
Relationships with Patient Organizations
Gilead provided support for the following patient organizations in 2017, via unrestricted educational grants. The information is correct at the time of writing (March 2018). The information is subject to change and periodic updates. For a listing of previous years’ grants,
| Recipient | Description of Activity | Amount Funded (EUR€) |
|---|---|---|
| ABRACO-AS APOIO PESSOAS HIV/SIDA | Project support "Community Center HSH + ABRAÇO" | 15.000,00 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | Project support "TEST@HOME" | 20.000,00 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | Project support "Madeira island quick tests" | 8.000,00 |
| ABRACO-AS APOIO PESSOAS HIV-SIDA | EACS Community Feedback Meeting | 102,68 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | HIV & Your Body, 15 - 16 Jun, Amsterdam | 638,16 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | MSM Campaign SC Meeting - 16/03/2017 - London - UK - Expenses | 640,92 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | MSM Campaign SC Meeting - 16/03/2017 - London - UK - Honoraria | 900,00 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | Viral Hepatitis, 11 - 12 May 2017, Prague | 543,52 |
| ABRACO-AS APOIO PESSOAS HIV/SIDA | Virology Meeting Point, Óbidos, 10 - 11 March | 430,50 |
| AGENCIA PIAGET P DESENVOLVIMENTO | Project in Gilead GÉNESE Fellowship program "ADERE+ -Promotion of Adherence to Therapeutics for HCV in the context of proximity to drug users" | 16.237,00 |
| AGENCIA PIAGET P DESENVOLVIMENTO | Viral Hepatitis, 11 - 12 May 2017, Prague | 1.069,92 |
| ASS AP D LEUCEMIAS E LINFOMAS | Oncology Advocacy - 10th Winter meeting, 29Mar, Porto,Auditorium CIM Faculdade Medicina Univ. Porto | 2.500,00 |
| ASS COMUN SOCIAL SAUDE - AJPAS | Community Advisory Board HIV - 6th September 2016 - Lisbon | 500,00 |
| ASS COMUN SOCIAL SAUDE - AJPAS | HIV & Your Body, 15 - 16 Jun, Amsterdam | 925,22 |
| ASS COMUN SOCIAL SAUDE - AJPAS | Virology Meeting Point, Óbidos, 10 - 11 March 2017 | 171,59 |
| ASS GRUPO APOIO SOS HEPATITES | 4th SOS Hepatites National Congess "Less Alcool Better Liver", 4 Feb 2017, Lisbon | 10.000,00 |
| ASS GRUPO APOIO SOS HEPATITES | ELPA University Module 4, Sarajevo , 12 - 15 March | 422,02 |
| ASS GRUPO APOIO SOS HEPATITES | Hepatits World Day, 28th July | 8.000,00 |
| ASS GRUPO APOIO SOS HEPATITES | Viral Hepatitis, 11 - 12 May 2017, Prague | 1.000,08 |
| ASS PLANEAM FAMILIA - LISBOA | Project in Gilead GÉNESE Fellowship program - "100 RISKS" | 21.330,00 |
| ASS PORT LEUCEMIAS E LINFOMAS | Project support "APLL Newsletter" | 2.400,00 |
| ASS POSITIVO | Project support "POSITIVO Screening Office" | 10.000,00 |
| ASS SER + | Support for "Anti-Discrimination Center" | 15.000,00 |
| ASS SER + | HIV & Your Body, 15 - 16 Jun, Amsterdam | 753,58 |
| ASS SER + | Grant - Support to mobile unit SER+ | 13.870,00 |
| ASS SER + | Virology Meeting Point, Óbidos, 10 - 11 March 2017 | 171,59 |
| ASS SERES CON(VIVER) COM VIH | Support for "Website and Facebook of SERES" | 3.000,00 |
| ASS SERES CON(VIVER) COM VIH | Support for "Website and Facebook of SERES" | 3.000,00 |
| ASS SERES CON(VIVER) COM VIH | Support to training program among peers | 11.000,00 |
| ASS SERES CON(VIVER) COM VIH | HIV & Your Body, 15 - 16 Jun, Amsterdam | 703,58 |
| ASS SERES CON(VIVER) COM VIH | Viral Hepatitis, 11 - 12 May 2017, Prague | 924,29 |
| ASSOCIACAO CASORGANIZADOS | SLTC Summit - 16/05/2017 - 16/05/2017 - Berlin - Germany | 1.805,73 |
| ASSOCIACAO CASORGANIZADOS | Viral Hepatitis, 11 - 12 May 2017, Prague | 1.232,71 |
| ASSOCIACAO CASORGANIZADOS | Virology Meeting Point, Óbidos, 10 - 11 March 2017 | 592,88 |
| AVENTURA SOCIAL - ASSOCIACAO | Project in Gilead GÉNESE Fellowship program - Study "Life without AIDs in Portugal" | 20.000,00 |
| CRESCER NA MAIOR | Virology Meeting Point, Óbidos, 10 - 11 March 2017 | 286,60 |
| FUNDACAO PORT COMUN CONTRA SIDA | Support for project "Training Plan 2017" | 4.000,00 |
| FUNDACAO PORT COMUN CONTRA SIDA | Community Advisory Board HIV - 6th Sep 2016 - Lisbon | 500,00 |
| FUNDACAO PORT COMUN CONTRA SIDA | HIV & Your Body, 15 - 16 Jun, Amsterdam | 863,93 |
| FUNDACAO PORT COMUN CONTRA SIDA | Virology Meeting Point, Óbidos, 10 11 March 2017 | 328,41 |
| GAT | Checkpoin | 15.000,00 |
| GAT | Project support "INTendente Space" | 10.000,00 |
| GAT | Project support "More participation better health: empower program +" | 7.500,00 |
| GAT | Screening network 2017 | 20.000,00 |
| GAT | Hepatitis C in drug users - from screening to linkage to care" "- July 19, 2017 - Porto | 247,50 |
| GAT | Aquisition of tickets for Gilead Employees to attend the solidarity essay at CCB | 600,00 |
| GAT | Community Advisory Board HIV - 6 Sep 2016 - Lisbon | 500,00 |
| GAT | HIV & Your Body, 15 - 16 Jun, Amsterdam | 955,22 |
| GAT | MDT Ad Board - HIV IS: Going Beyond Undetectable - 28/11/2016 - 29/11/2016 - London - UK | 1.561,53 |
| GAT | Test European Week | 10.000,00 |
| GAT | Virology Meeting Point, Óbidos, 10 - 11 March 2017 | 581,81 |
| GAT | Virology Meeting Point, Óbidos, 10 - 11 march 2017 (honoraria) | 350,00 |
| LIGA PORTUGUESA CONTRA SIDA | Community Advisory Board HIV - 6th September 2016 - Lisbon | 500,00 |
| LIGA PORTUGUESA CONTRA SIDA | HIV & Your Body, 15 - 16 Jun, Amsterdam | 975,22 |
| LIGA PORTUGUESA CONTRA SIDA | Check-up Initiative , Lisbon and Porto, 4 - 6 November | 5.000,00 |
The information on the grants given by Gilead Sciences, Lda. To the Patients’ Organizations listed herein is available upon request by any interested party.
This page is intended for visitors outside of the United States.